Equities research analysts at Piper Jaffray Companies initiated coverage on shares of Envision Healthcare (NYSE:EVHC) in a research note issued to investors on Wednesday. The firm set a “neutral” rating and a $35.00 price target on the stock. Piper Jaffray Companies’ price target would suggest a potential upside of 6.19% from the company’s previous close.
Other equities analysts also recently issued reports about the company. Canaccord Genuity reissued a “buy” rating and set a $32.00 target price (down from $68.00) on shares of Envision Healthcare in a research note on Thursday, November 2nd. Robert W. Baird reissued a “buy” rating and set a $70.00 target price on shares of Envision Healthcare in a research note on Tuesday, October 17th. SunTrust Banks set a $55.00 target price on Envision Healthcare and gave the stock a “buy” rating in a research note on Sunday, October 15th. Bank of America cut their target price on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, October 9th. Finally, Jefferies Group set a $71.00 target price on Envision Healthcare and gave the stock a “buy” rating in a research note on Thursday, August 24th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Envision Healthcare has an average rating of “Buy” and an average target price of $46.06.
Envision Healthcare (NYSE EVHC) traded down $0.41 during trading on Wednesday, reaching $32.96. The company’s stock had a trading volume of 2,424,300 shares, compared to its average volume of 2,267,795. The firm has a market cap of $4,034.08, a PE ratio of 10.30, a price-to-earnings-growth ratio of 0.87 and a beta of 0.57. Envision Healthcare has a 52 week low of $23.77 and a 52 week high of $73.00. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89.
Envision Healthcare (NYSE:EVHC) last issued its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business’s quarterly revenue was up 142.0% on a year-over-year basis. During the same period last year, the company posted $1.13 earnings per share. equities analysts predict that Envision Healthcare will post 2.56 EPS for the current year.
Envision Healthcare declared that its board has authorized a stock repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sawtooth Solutions LLC grew its holdings in Envision Healthcare by 0.7% during the 2nd quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock valued at $417,000 after buying an additional 43 shares during the last quarter. Boys Arnold & Co. Inc. grew its holdings in Envision Healthcare by 0.6% during the 2nd quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock valued at $509,000 after buying an additional 50 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Envision Healthcare by 1.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after buying an additional 70 shares during the last quarter. Utah Retirement Systems grew its holdings in Envision Healthcare by 0.5% during the 2nd quarter. Utah Retirement Systems now owns 21,289 shares of the company’s stock valued at $1,335,000 after buying an additional 100 shares during the last quarter. Finally, M&T Bank Corp grew its holdings in Envision Healthcare by 2.7% during the 2nd quarter. M&T Bank Corp now owns 5,420 shares of the company’s stock valued at $341,000 after buying an additional 141 shares during the last quarter.
TRADEMARK VIOLATION NOTICE: “Piper Jaffray Companies Initiates Coverage on Envision Healthcare (EVHC)” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://ledgergazette.com/2017/12/15/piper-jaffray-companies-initiates-coverage-on-envision-healthcare-evhc.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.